Showing results (151-160 of 324) with videos related to
Sort By:
Pageof 33
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 30, 2006
LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytesR Carnevale, P Pignatelli, L Lenti, et al.Mineral and Electrolyte Metabolism|April 20, 1999
Early dialysis in heart insufficiency of patients with chronic renal failureL Iorio, R Simonelli, G Saltarelli, et al.Hepatology (Baltimore, Md.)|June 1, 1996
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemiaD Ferro, C Quintarelli, A Lattuada, et al.The Journal of Laboratory and Clinical Medicine|April 1, 1992
Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagenD Pratico, L Iuliano, F M Pulcinelli, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 1, 2009
[Effectiveness of daptomycin in the treatment of patients on hemodialysis affected by CVC infection]F Violi, R G Nacca, F Lamberti, et al.Journal of the American College of Cardiology|January 12, 2001
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCAL Iuliano, D Praticò, C Greco, et al.Annals of Neurology|November 18, 2000
Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivoD Praticò, L Iuliano, G Amerio, et al.BMJ (Clinical Research Ed.)|April 28, 1990
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosisF Violi, D Ferro, G Valesini, et al.American Journal of Hypertension|October 1, 1990
Plasma atrial natriuretic peptide in young normotensive subjects with a family history of hypertension and in young hypertensive patientsA Santucci, C Ferri, I Cammarella, et al.Clinical Drug Investigation|May 26, 2007
Efficacy, safety and tolerability of combined low-dose simvastatin-fenofibrate treatment in primary mixed hyperlipidaemiaC Stefanutti, A Bucci, S Di Giacomo, et al.Pageof 33